Driehaus Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,800	Closed	-$219K	–	476
2018 Q1	$219K	Buy	+4,800	New	+$219K	0.01%	464